2,522 Shares in CME Group Inc. $CME Purchased by Expressive Wealth LLC

Expressive Wealth LLC acquired a new stake in CME Group Inc. (NASDAQ:CME) in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 2,522 shares of the financial services provider’s stock, valued at approximately $557,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of CME. Whipplewood Advisors LLC raised its position in shares of CME Group by 2,075.0% during the 1st quarter. Whipplewood Advisors LLC now owns 87 shares of the financial services provider’s stock valued at $26,000 after acquiring an additional 83 shares in the last quarter. Elkhorn Partners Limited Partnership bought a new position in CME Group during the fourth quarter worth $27,000. Hilton Head Capital Partners LLC acquired a new position in CME Group in the fourth quarter worth $28,000. Legacy Wealth Managment LLC ID boosted its holdings in CME Group by 191.9% in the fourth quarter. Legacy Wealth Managment LLC ID now owns 108 shares of the financial services provider’s stock worth $29,000 after purchasing an additional 71 shares during the period. Finally, Main Street Group LTD bought a new stake in CME Group during the first quarter valued at $32,000. Institutional investors and hedge funds own 87.75% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have weighed in on CME. Deutsche Bank Aktiengesellschaft cut shares of CME Group from a “buy” rating to a “hold” rating and dropped their target price for the stock from $286.00 to $270.00 in a report on Wednesday. Rothschild & Co Redburn raised shares of CME Group from a “neutral” rating to a “buy” rating and lifted their price target for the company from $316.00 to $323.00 in a report on Thursday, June 11th. UBS Group lowered their price objective on shares of CME Group from $310.00 to $260.00 and set a “buy” rating for the company in a research report on Monday, July 6th. The Goldman Sachs Group dropped their price objective on shares of CME Group from $267.00 to $245.00 and set a “sell” rating on the stock in a research note on Tuesday, June 30th. Finally, Piper Sandler cut their target price on shares of CME Group from $329.00 to $295.00 and set an “overweight” rating on the stock in a report on Wednesday, July 15th. Nine equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus price target of $288.56.

CME Group Price Performance

Shares of CME opened at $274.98 on Friday. The company has a market cap of $98.88 billion, a P/E ratio of 23.32, a PEG ratio of 3.16 and a beta of 0.23. The stock has a fifty day moving average price of $251.17 and a 200 day moving average price of $279.65. The company has a debt-to-equity ratio of 0.13, a current ratio of 1.02 and a quick ratio of 1.02. CME Group Inc. has a 12 month low of $218.31 and a 12 month high of $329.16.

CME Group (NASDAQ:CME) last posted its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $2.91 by $0.08. CME Group had a return on equity of 15.60% and a net margin of 63.30%.The company had revenue of $1.71 billion for the quarter, compared to analysts’ expectations of $1.68 billion. During the same period last year, the business posted $2.96 earnings per share. The firm’s quarterly revenue was up .8% compared to the same quarter last year. On average, research analysts forecast that CME Group Inc. will post 12.27 earnings per share for the current year.

CME Group Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Investors of record on Wednesday, September 9th will be issued a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a dividend yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group’s dividend payout ratio (DPR) is 44.11%.

Insiders Place Their Bets

In other news, Director William R. Shepard acquired 325 shares of the business’s stock in a transaction that occurred on Thursday, June 25th. The shares were purchased at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the transaction, the director directly owned 260,442 shares in the company, valued at $60,050,111.94. This trade represents a 0.12% increase in their position. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.30% of the stock is currently owned by corporate insiders.

About CME Group

CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.

The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.